Argentina vs Guatemala: New cases tested for RR-/MDR-TB
Argentina
56.0%
in 2024
Guatemala
52.0%
in 2024
Argentina rank
158th
Guatemala rank
160th
New cases tested for RR-/MDR-TB over time
- Argentina
- Guatemala
How they compare
Argentina currently reports 56.0% against 52.0% in Guatemala, a difference of 4.0%.
That makes Argentina's figure about 1.1 times Guatemala's.
The two have swapped places 4 times across 14 shared years of data; in 2005 it was Argentina ahead.
Argentina ranks 158th and Guatemala ranks 160th of 192 countries.
Across the 3 decades both report, Argentina averaged higher in 1 and Guatemala in 2.
Head to head by decade
| Decade | Argentina | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.0% | 0.8% | 45.2% | Argentina |
| 2010s | 17.9% | 23.4% | 5.5% | Guatemala |
| 2020s | 40.6% | 70.0% | 29.4% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Argentina or Guatemala?
- Argentina, at 56.0% against 52.0% in Guatemala as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Argentina and Guatemala?
- 4.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Guatemala?
- 14 years are reported by both, from 2005 to 2024.
- How do Argentina and Guatemala rank globally for new cases tested for rr-/mdr-tb?
- Argentina ranks 158th and Guatemala ranks 160th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.